Bad News on Anti-HER2 Heart Effects Exercise, however, may help improve cardio fitness in breast cancer survivors Jan 15, 2020
Oral Paclitaxel Bests IV Delivery in Advanced Breast Cancer But high pill count, lengthy dosing schedule could prove to be problematic Dec 14, 2019
Residual Breast Cancer Tool Highly Prognostic After Neoadjuvant Tx Tumor burden calculator predicted long-term outcomes in all breast cancer subtypes Dec 14, 2019
Anti-CDK4/6 Fails to Top Chemo in HR-Positive MBC Similar PFS with chemo, palbociclib plus exemestane or fulvestrant after progression on aromatase inhibitor Dec 13, 2019
HRT Has 20-Year Impact on Breast Cancer Risks Prospective data confirm long-term benefit with estrogen-only and harm with added progestin Dec 13, 2019
Checkpoints Show Different Outcomes in Breast Cancer Atezolizumab misses complete response benefit in triple negative patients Dec 13, 2019
T-DM1 Falls Short as Less-Toxic Option for Early Breast Cancer Promising efficacy but higher discontinuation rates and cost likely a deterrent Dec 13, 2019
Edging Closer to OS Benefit With Novel Anti-HER2 Drug Larger benefit with margetuximab in most common HER2 breast cancer phenotype Dec 12, 2019
New Standard for Metastatic HER2 Breast Cancer Consistent PFS, OS benefit with combination including oral HER2 inhibitor tucatinib Dec 11, 2019
Study Suggests Viable Alternative to Mastectomy After In-Breast Recurrence Mastectomy rates low, good cancer control in selected patients Nov 21, 2019
Sex Assault at Mt. Sinai; Pharma's MD Millionaires; Mammography Marketing Machine This past week in healthcare investigations Oct 23, 2019
Novel CDK 4/6 Inhibitor Fails in Triple Negative Breast Cancer Misses primary endpoints but has unexpected key benefit Oct 01, 2019
Neoadjuvant Anti-PD-1 Boosts pCR in TNBC Favorable trend toward improved event-free survival in preliminary analysis Sep 30, 2019
CDK 4/6 Inhibitors Boost OS in Advanced Breast Cancer Abemaciclib, ribociclib should become first-line treatment in HR-positive/HER2-negative disease, expert says Sep 29, 2019
Abemaciclib Offers Hope in HR+/HER2+Breast Cancer Phase II monarcHER trial shows better PFS with abemaciclib-trastuzumab-fulvestrant Sep 29, 2019
Wires or RFID Tags in Breast Cancer Excision? Women like the less obtrusive method, but small study doesn't quite settle question of whether there's a tradeoff Sep 24, 2019
The Legacy of Henry Lynch, MD Earlier this summer the legendary researcher passed, his contributions to cancer research are immeasurable Sep 01, 2019
Olivia Newton-John's Stage 4 Cancer Cannabis Management The singer and actress updates fans on her battle, but can marijuana help? Aug 22, 2019
MRI Screening Finds More Breast Cancers, but at What Cost? Even breast cancer survivors may find it tough to sort out benefits and harms Jul 24, 2019
No Cancer Risk Found With TNF Inhibitors in Psoriatic Arthritis Expected cancer cases similar to those in general populace, study shows Jun 13, 2019
Jury Out on Margetuximab in Advanced HER2+ Breast Cancer One-month PFS boost, but certain subgroups may derive more benefit Jun 05, 2019
Cancer Surgery Refusal Remains a Problem Older, unmarried, African-American patients more likely to say 'no' Jun 04, 2019
Dramatic OS Boost With Kisqali in Young Breast Ca Patients 'First study to demonstrate improved survival for a targeted therapy' in advanced disease Jun 02, 2019 video
Hormones Tied to Increased Breast Cancer Risk for Trans Women Overall risk still lower than cisgender women, however, and small overall May 14, 2019
Detailed Policy Cuts Opioid Use After Breast Ca Surgery 40% of women reported zero narcotic use after surgery May 03, 2019
Omitting Chemo Feasible in First-Line HER2+ Breast Cancer? De-escalation showed mixed results in metastatic disease May 01, 2019
CAR T-Cell Therapy Active in Solid Tumors Preliminary data on safety, efficacy in mesothelioma, sarcomas Mar 31, 2019 video
Are Patients Better Off With Image-Guided Bone Marrow Biopsy? Prospect of sedation has some going to interventional radiology Mar 29, 2019
Vaccine Prolongs Remission in Triple-Negative Breast Cancer Effect in hard-to-treat subgroup "clinically meaningful" Mar 07, 2019
Black History Month: Talking With Jennifer Webb, MD How mentorship helped her overcome barriers Feb 28, 2019
Patients Say Quality of Life Suffered With Mastectomy for Early Breast Cancer Breast-conservation options were associated with better sexual, psychosocial outcomes Dec 07, 2018
SABCS: Axillary RT as Good as Surgery in Breast Cancer Radiation non-inferior to surgery after positive sentinel node Dec 07, 2018
Low-Dose Tamoxifen Feasible Option in Breast Cancer Women appear to prevent recurrence in early stage cancers with 5 mg dosing Dec 06, 2018
Xeloda Disappoints in Early Triple-Negative Breast Cancer No improvement after standard chemo, though subset may derive some benefit Dec 05, 2018
T-DM1: A New Adjuvant Standard in High-Risk HER2+ Breast Ca? Substantial improvements in survival outcomes in KATHERINE trial Dec 05, 2018
SABCS: Translational Before It Was Cool Growing, evolving while adhering to founding principles Dec 03, 2018
Younger High-Risk Women Benefit From Mammography Yields in 30-39 age group at high risk comparable to 40-49 group with average risk Nov 30, 2018
Machine Learning Allows for Low-Dose Gadolinium Contrast Minimal loss of resolution with 10% Gd dose Nov 30, 2018
